News | May 12, 2022
Suven Pharmaceuticals - CDMO core growth intact; formulations to pick up
Anand Rathi maintains long-term guidance of 10-15% revenue growth and 40% EBITDA margins
Anand Rathi maintains long-term guidance of 10-15% revenue growth and 40% EBITDA margins
Bora establishes a leadership position in Taiwan's CDMO sector as it continues to expand into the global CDMO market
Takeda and United Nations Global Compact Network of India (UNGCNI) join hands
Upon closing, the Quakertown business will become an independent company called Microsize
This agreement is truly remarkable for achieving greater objectives in the projects and addressing larger problems
The new hub, which brings Avantor solutions closer to regional customers and strengthens global supply chain capabilities, will be fully operational early next year
This partnership expands DNA Script’s footprint and provides sales and support for the SYNTAX System DNA printer in labs in India
Company will expand the existing production site in Wuxi to significantly increase biopharma single-use assemblies and custom design capabilities
The report has estimated 4.74 million deaths for India in 2020 and 2021,
Onshore manufacturing facility is expected to be based in Quebec and produce up to 100 million mRNA respiratory vaccine doses annually
Subscribe To Our Newsletter & Stay Updated
